glp 1 uses GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders Your guide to GLP-1 side

Consult a healthcare professional before discontinuing use of GLP-1 medication

Together, theyre worth knowing

46,47,99,100 Data available from the open label clinical trial in PD involving exenatide in the form of Byetta 99,100 and Bydureon in the double-blind trial 47 suggests that the agent proved to be well tolerated in PD subjects

Protein-first eating at every meal is the practical strategy for hitting this target despite reduced appetite

Which compound fits which goals After examining the clinical data, mechanisms, side effects, and availability, the question becomes practical

But the real GLP-1 story appears to be just getting started